2012•New England Journal of MedicineOpen access

Failures of Cobalamin Assays in Pernicious Anemia

Ralph Carmel, Yash Pal Agrawal

Open full text 115 citations

Abstract

The authors show that commercial tests for cobalamin levels provide false normal values in 22 to 35% of cases of pernicious anemia, the main disease they were designed to detect. The manufacturers need to solve the problem of interference of the assay by antibodies to intrinsic factor.

Open-access reader

About this research paper

What this paper is about

The authors show that commercial tests for cobalamin levels provide false normal values in 22 to 35% of cases of pernicious anemia, the main disease they were designed to detect. The manufacturers need to solve the problem of interference of the assay by antibodies to intrinsic factor.

Why it matters

OpenAlex reports 115 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The authors show that commercial tests for cobalamin levels provide false normal values in 22 to 35% of cases of pernicious anemia, the main disease they were designed to detect. The manufacturers need to solve the problem of interference of the assay by antibodies to intrinsic factor.

Key concepts: Cobalamin, pernicious anemia, Medicine, Intrinsic factor, Anemia, Pernicious anaemia, Vitamin B12, Physiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Failures of Cobalamin Assays in Pernicious Anemia — Research Paper | ScholarLens